COMPANY NEWS


Aurobindo Pharma Ltd
BSE Code 524804 ISIN Demat INE406A01037 Book Value (₹) 318.55 NSE Symbol AUROPHARMA Div & Yield % 0.65 Market Cap ( Cr.) 67,541.14 P/E * 34.35 EPS * 33.56 Face Value (₹) 1
* Profit to Earning Ratio
* Earning Per Share
Aurobindo Pharma unit clears USFDA audit Back
(16 Feb 2024)
Aurobindo Pharma announced that the manufacturing unit of Auro Peptides, the synthetic peptides API business arm of the company, situated at Indrakaran Village, Kandi Mandal, Sangareddy District, Telangana, was audited by the US FDA from 12 - 16 February 2024. The inspection was concluded with zero observations.